UNAIDS is championing the inaugural #WhatWomenWant Day on 6 April. Led by the Athena Network, the day sees the launch of the report #WhatWomenWant: a transformative framework for women, girls and gender equality in the context of HIV and sexual and reproductive health and rights. The ...

Kaiser Family Foundation: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) This updated fact sheet examines the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and its role in addressing global HIV/AIDS, including treatment and prevention targets, results, funding, and challenges (4/5). Source

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 308 of the “Global Fund Observer.” The newsletter features articles on various topics, including a news article on how the Trump administration’s budget proposals will impact the Global Fund, ...

The starting point for this guideline is the point at which a woman has learnt that she is living with HIV, and it therefore covers key issues for providing comprehensive sexual and reproductive health and rights-related services and support for women living with HIV. As ...

A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits. The report shows that, on average for these top companies, ...

More than a third of HIV patients develop oral conditions from immune systems compromised by the virus and its treatment, according to the National Institutes of Health (NIH) While advances in HIV treatment have dramatically improved patient lifespans and quality of life, nagging side effects remain; ...

Neither the government nor CSOs have taken up the services previously supported by the Global Fund In January 2017, the Ministry of Finance of the Russian Federation rejected a request to allocate $1.2 billion over four years for the response to HIV, citing “a lack of ...

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time we started giving PrEP to all breastfed babies of HIV-positive mothers in countries where the likelihood of transmission via breastfeeding ...

ECUO team is pleased to present free online access to Community Regional Action Plan for Enhancing Sustainable Access to Quality and Continuous HIV Care for All Who Need It in Eastern Europe and Central Asia in 2017-2020 (Regional Plan). The developed Regional Plan is a ...

Central Asia and the Russian Federation face a major intra-regional migration flow, home, as it is, to one of the largest labor migration corridors in the world, with hundreds of thousands of migrant workers moving from Central Asian countries to the Russian Federation and to ...

High drug pricing for interferon-free direct acting antiviral regimens (up to US$93 000 per 12 week course) has limited broad implementation in the vast majority of settings, with restrictions based on liver disease stage generally introduced to reduce budget impact. Other restrictions, including those based on ...

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. It publishes translational, epidemiological, clinical, operational, and implementation studies. The April 2017 issue is available here. Source

Implant could offer long-acting, removable form of prevention not currently available Chapel Hill, NC – Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system ...

Patent opposition aims to increase affordable access to hepatitis C drug sofosbuvir for millions Rome/Geneva, 27 March 2017 – The international medical humanitarian organisation Médecins Sans Frontières (MSF) has today filed a patent challenge on the hepatitis C drug sofosbuvir with the European Patent Office (EPO) ...

Testing all patients is vital if the proportion of HIV co-infections is to fall in the European Union and European Economic Area, the World Health Organization has announced ahead of World TB Day 2017. The proportion of people in Europe living with tuberculosis (TB) and HIV ...

After three years, tenofovir alafenamide (TAF) for first-line HIV treatment was better at suppressing viral load and safer for the bones and kidneys than the older tenofovir disoproxil fumarate (TDF), researchers reported at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) last month in ...

Living with HIV in Ukraine is fraught with stigma and discrimination. It’s even harder if you’re a woman. On International Women’s Day in early March, the Joint United Nations Programme on HIV/AIDS (UNAIDS) published a report stating there is an “urgent need” to increase HIV treatment ...

Copenhagen and Stockholm, 20 March 2017 New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis (TB) cases and deaths in the 53 countries of the ...